{
  "summary": {
    "total_tests": 139,
    "equivalent_results": 103,
    "different_results": 36,
    "high_significance_differences": 15,
    "medium_significance_differences": 21,
    "low_significance_differences": 0,
    "differences_by_focus": {
      "blast_thresholds": 9,
      "therapy_qualifiers": 1,
      "tp53_terminology": 6,
      "mds_blast_ranges": 10,
      "erythroid_handling": 8,
      "combination_scenarios": 2
    },
    "differences_by_category": {
      "major_category_difference": 9,
      "diagnostic_uncertainty": 6,
      "category_difference": 21
    }
  },
  "test_results": [
    {
      "test_id": "test_000001",
      "input_data": {
        "blasts_percentage": 9,
        "AML_defining_recurrent_genetic_abnormalities": {
          "CEBPA": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: CEBPA",
        "CEBPA found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 9, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => CEBPA",
        "No single ICC AML-def abnormality triggered classification.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 9",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.650992"
    },
    {
      "test_id": "test_000002",
      "input_data": {
        "blasts_percentage": 9,
        "AML_defining_recurrent_genetic_abnormalities": {
          "bZIP": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: bZIP",
        "bZIP found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 9, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => bZIP",
        "bZIP but blasts <10 => cannot label AML here",
        "No single ICC AML-def abnormality triggered classification.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 9",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651228"
    },
    {
      "test_id": "test_000003",
      "input_data": {
        "blasts_percentage": 9,
        "AML_defining_recurrent_genetic_abnormalities": {
          "BCR::ABL1": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: BCR::ABL1",
        "BCR::ABL1 found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 9, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => BCR::ABL1",
        "BCR::ABL1 but blasts <10 => cannot label AML here",
        "No single ICC AML-def abnormality triggered classification.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 9",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651264"
    },
    {
      "test_id": "test_000004",
      "input_data": {
        "blasts_percentage": 9,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with NPM1 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 but blasts <10 => cannot label AML here",
        "No single ICC AML-def abnormality triggered classification.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 9",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "MDS",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation",
        "icc_classification": "MDS with excess blasts",
        "who_category": "AML_GENETIC",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "major_category_difference",
        "significance": "high"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651302"
    },
    {
      "test_id": "test_000005",
      "input_data": {
        "blasts_percentage": 10,
        "AML_defining_recurrent_genetic_abnormalities": {
          "CEBPA": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: CEBPA",
        "CEBPA found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 10, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => CEBPA",
        "No single ICC AML-def abnormality triggered classification.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651346"
    },
    {
      "test_id": "test_000006",
      "input_data": {
        "blasts_percentage": 10,
        "AML_defining_recurrent_genetic_abnormalities": {
          "bZIP": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "AML with in-frame bZIP mutated CEBPA (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: bZIP",
        "bZIP found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 10, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => bZIP",
        "bZIP => AML with in-frame bZIP mutated CEBPA",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with in-frame bZIP mutated CEBPA (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "AML with in-frame bZIP mutated CEBPA",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_GENETIC",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "major_category_difference",
        "significance": "high"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651387"
    },
    {
      "test_id": "test_000007",
      "input_data": {
        "blasts_percentage": 10,
        "AML_defining_recurrent_genetic_abnormalities": {
          "BCR::ABL1": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: BCR::ABL1",
        "BCR::ABL1 found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 10, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => BCR::ABL1",
        "BCR::ABL1 => AML with t(9;22)(q34.1;q11.2)/BCR::ABL1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with t(9;22)(q34.1;q11.2)/BCR::ABL1 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_GENETIC",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "major_category_difference",
        "significance": "high"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651427"
    },
    {
      "test_id": "test_000008",
      "input_data": {
        "blasts_percentage": 10,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with NPM1 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated NPM1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation",
        "icc_classification": "AML with mutated NPM1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651449"
    },
    {
      "test_id": "test_000009",
      "input_data": {
        "blasts_percentage": 15,
        "AML_defining_recurrent_genetic_abnormalities": {
          "CEBPA": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: CEBPA",
        "CEBPA found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => CEBPA",
        "No single ICC AML-def abnormality triggered classification.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651490"
    },
    {
      "test_id": "test_000010",
      "input_data": {
        "blasts_percentage": 15,
        "AML_defining_recurrent_genetic_abnormalities": {
          "bZIP": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "AML with in-frame bZIP mutated CEBPA (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: bZIP",
        "bZIP found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => bZIP",
        "bZIP => AML with in-frame bZIP mutated CEBPA",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with in-frame bZIP mutated CEBPA (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "AML with in-frame bZIP mutated CEBPA",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_GENETIC",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "major_category_difference",
        "significance": "high"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651527"
    },
    {
      "test_id": "test_000011",
      "input_data": {
        "blasts_percentage": 15,
        "AML_defining_recurrent_genetic_abnormalities": {
          "BCR::ABL1": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: BCR::ABL1",
        "BCR::ABL1 found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => BCR::ABL1",
        "BCR::ABL1 => AML with t(9;22)(q34.1;q11.2)/BCR::ABL1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with t(9;22)(q34.1;q11.2)/BCR::ABL1 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_GENETIC",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "major_category_difference",
        "significance": "high"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651564"
    },
    {
      "test_id": "test_000012",
      "input_data": {
        "blasts_percentage": 15,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with NPM1 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated NPM1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation",
        "icc_classification": "AML with mutated NPM1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651585"
    },
    {
      "test_id": "test_000013",
      "input_data": {
        "blasts_percentage": 19,
        "AML_defining_recurrent_genetic_abnormalities": {
          "CEBPA": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: CEBPA",
        "CEBPA found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 19, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => CEBPA",
        "No single ICC AML-def abnormality triggered classification.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651623"
    },
    {
      "test_id": "test_000014",
      "input_data": {
        "blasts_percentage": 19,
        "AML_defining_recurrent_genetic_abnormalities": {
          "bZIP": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "AML with in-frame bZIP mutated CEBPA (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: bZIP",
        "bZIP found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 19, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => bZIP",
        "bZIP => AML with in-frame bZIP mutated CEBPA",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with in-frame bZIP mutated CEBPA (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "AML with in-frame bZIP mutated CEBPA",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_GENETIC",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "major_category_difference",
        "significance": "high"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651659"
    },
    {
      "test_id": "test_000015",
      "input_data": {
        "blasts_percentage": 19,
        "AML_defining_recurrent_genetic_abnormalities": {
          "BCR::ABL1": true
        },
        "qualifiers": {},
        "expected_difference": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: BCR::ABL1",
        "BCR::ABL1 found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 19, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => BCR::ABL1",
        "BCR::ABL1 => AML with t(9;22)(q34.1;q11.2)/BCR::ABL1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with t(9;22)(q34.1;q11.2)/BCR::ABL1 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_GENETIC",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "major_category_difference",
        "significance": "high"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651696"
    },
    {
      "test_id": "test_000016",
      "input_data": {
        "blasts_percentage": 19,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with NPM1 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated NPM1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation",
        "icc_classification": "AML with mutated NPM1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651716"
    },
    {
      "test_id": "test_000017",
      "input_data": {
        "blasts_percentage": 20,
        "AML_defining_recurrent_genetic_abnormalities": {
          "CEBPA": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with CEBPA mutation (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: CEBPA",
        "CEBPA with blasts >=20 => AML with CEBPA mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with CEBPA mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => CEBPA",
        "No single ICC AML-def abnormality triggered classification.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "AML with CEBPA mutation",
        "icc_classification": "AML, NOS",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_NOS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "major_category_difference",
        "significance": "high"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651754"
    },
    {
      "test_id": "test_000018",
      "input_data": {
        "blasts_percentage": 20,
        "AML_defining_recurrent_genetic_abnormalities": {
          "bZIP": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with CEBPA mutation (WHO 2022)",
      "icc_classification": "AML with in-frame bZIP mutated CEBPA (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: bZIP",
        "bZIP with blasts >=20 => AML with CEBPA mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with CEBPA mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => bZIP",
        "bZIP => AML with in-frame bZIP mutated CEBPA",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with in-frame bZIP mutated CEBPA (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with CEBPA mutation",
        "icc_classification": "AML with in-frame bZIP mutated CEBPA",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651778"
    },
    {
      "test_id": "test_000019",
      "input_data": {
        "blasts_percentage": 20,
        "AML_defining_recurrent_genetic_abnormalities": {
          "BCR::ABL1": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with BCR::ABL1 fusion (WHO 2022)",
      "icc_classification": "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: BCR::ABL1",
        "BCR::ABL1 with blasts >=20 => AML with BCR::ABL1 fusion",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with BCR::ABL1 fusion (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => BCR::ABL1",
        "BCR::ABL1 => AML with t(9;22)(q34.1;q11.2)/BCR::ABL1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with t(9;22)(q34.1;q11.2)/BCR::ABL1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with BCR::ABL1 fusion",
        "icc_classification": "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651803"
    },
    {
      "test_id": "test_000020",
      "input_data": {
        "blasts_percentage": 20,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with NPM1 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated NPM1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation",
        "icc_classification": "AML with mutated NPM1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651823"
    },
    {
      "test_id": "test_000021",
      "input_data": {
        "blasts_percentage": 25,
        "AML_defining_recurrent_genetic_abnormalities": {
          "CEBPA": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with CEBPA mutation (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: CEBPA",
        "CEBPA with blasts >=20 => AML with CEBPA mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with CEBPA mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => CEBPA",
        "No single ICC AML-def abnormality triggered classification.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "AML with CEBPA mutation",
        "icc_classification": "AML, NOS",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_NOS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "major_category_difference",
        "significance": "high"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651872"
    },
    {
      "test_id": "test_000022",
      "input_data": {
        "blasts_percentage": 25,
        "AML_defining_recurrent_genetic_abnormalities": {
          "bZIP": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with CEBPA mutation (WHO 2022)",
      "icc_classification": "AML with in-frame bZIP mutated CEBPA (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: bZIP",
        "bZIP with blasts >=20 => AML with CEBPA mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with CEBPA mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => bZIP",
        "bZIP => AML with in-frame bZIP mutated CEBPA",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with in-frame bZIP mutated CEBPA (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with CEBPA mutation",
        "icc_classification": "AML with in-frame bZIP mutated CEBPA",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651899"
    },
    {
      "test_id": "test_000023",
      "input_data": {
        "blasts_percentage": 25,
        "AML_defining_recurrent_genetic_abnormalities": {
          "BCR::ABL1": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with BCR::ABL1 fusion (WHO 2022)",
      "icc_classification": "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: BCR::ABL1",
        "BCR::ABL1 with blasts >=20 => AML with BCR::ABL1 fusion",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with BCR::ABL1 fusion (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => BCR::ABL1",
        "BCR::ABL1 => AML with t(9;22)(q34.1;q11.2)/BCR::ABL1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with t(9;22)(q34.1;q11.2)/BCR::ABL1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with BCR::ABL1 fusion",
        "icc_classification": "AML with t(9;22)(q34.1;q11.2)/BCR::ABL1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651924"
    },
    {
      "test_id": "test_000024",
      "input_data": {
        "blasts_percentage": 25,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {},
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with NPM1 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated NPM1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation",
        "icc_classification": "AML with mutated NPM1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "blast_thresholds",
      "timestamp": "2025-06-06T19:25:13.651944"
    },
    {
      "test_id": "test_000025",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "Immune interventions"
        },
        "expected_difference": true
      },
      "who_classification": "AML with NPM1 mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with NPM1 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "Detected ICC therapy => therapy related: Immune interventions",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML with mutated NPM1, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation",
        "icc_classification": "AML with mutated NPM1, therapy related",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.651978"
    },
    {
      "test_id": "test_000026",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "RUNX1::RUNX1T1": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "Immune interventions"
        },
        "expected_difference": true
      },
      "who_classification": "AML with RUNX1::RUNX1T1 fusion (WHO 2022)",
      "icc_classification": "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: RUNX1::RUNX1T1",
        "RUNX1::RUNX1T1 => AML with RUNX1::RUNX1T1 fusion",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with RUNX1::RUNX1T1 fusion (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => RUNX1::RUNX1T1",
        "RUNX1::RUNX1T1 => AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1",
        "Detected ICC therapy => therapy related: Immune interventions",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with RUNX1::RUNX1T1 fusion",
        "icc_classification": "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652014"
    },
    {
      "test_id": "test_000027",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "qualifiers": {
          "previous_cytotoxic_therapy": "Immune interventions"
        },
        "expected_difference": true
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML, NOS, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "Detected ICC therapy => therapy related: Immune interventions",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML, NOS, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML, NOS, therapy related",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "AML_THERAPY_RELATED",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "diagnostic_uncertainty",
        "significance": "high"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652058"
    },
    {
      "test_id": "test_000028",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "Ionising radiation"
        },
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation, previous cytotoxic therapy (WHO 2022)",
      "icc_classification": "AML with mutated NPM1, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "Detected WHO therapy => previous cytotoxic therapy: Ionising radiation",
        "No germline predisposition indicated (review at MDT)",
        "Classification with qualifiers => AML with NPM1 mutation, previous cytotoxic therapy",
        "Final classification => AML with NPM1 mutation, previous cytotoxic therapy (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "Detected ICC therapy => therapy related: Ionising radiation",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML with mutated NPM1, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation, previous cytotoxic therapy",
        "icc_classification": "AML with mutated NPM1, therapy related",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652094"
    },
    {
      "test_id": "test_000029",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "RUNX1::RUNX1T1": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "Ionising radiation"
        },
        "expected_difference": false
      },
      "who_classification": "AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy (WHO 2022)",
      "icc_classification": "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: RUNX1::RUNX1T1",
        "RUNX1::RUNX1T1 => AML with RUNX1::RUNX1T1 fusion",
        "No AML_differentiation provided.",
        "Detected WHO therapy => previous cytotoxic therapy: Ionising radiation",
        "No germline predisposition indicated (review at MDT)",
        "Classification with qualifiers => AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy",
        "Final classification => AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => RUNX1::RUNX1T1",
        "RUNX1::RUNX1T1 => AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1",
        "Detected ICC therapy => therapy related: Ionising radiation",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy",
        "icc_classification": "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652132"
    },
    {
      "test_id": "test_000030",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "qualifiers": {
          "previous_cytotoxic_therapy": "Ionising radiation"
        },
        "expected_difference": false
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy (WHO 2022)",
      "icc_classification": "AML, NOS, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "Detected WHO therapy => previous cytotoxic therapy: Ionising radiation",
        "No germline predisposition indicated (review at MDT)",
        "Classification with qualifiers => Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy",
        "Final classification => Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "Detected ICC therapy => therapy related: Ionising radiation",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML, NOS, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy",
        "icc_classification": "AML, NOS, therapy related",
        "who_category": "AML_THERAPY_RELATED",
        "icc_category": "AML_THERAPY_RELATED",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652174"
    },
    {
      "test_id": "test_000031",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "Cytotoxic chemotherapy"
        },
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation, previous cytotoxic therapy (WHO 2022)",
      "icc_classification": "AML with mutated NPM1, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "Detected WHO therapy => previous cytotoxic therapy: Cytotoxic chemotherapy",
        "No germline predisposition indicated (review at MDT)",
        "Classification with qualifiers => AML with NPM1 mutation, previous cytotoxic therapy",
        "Final classification => AML with NPM1 mutation, previous cytotoxic therapy (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "Detected ICC therapy => therapy related: Cytotoxic chemotherapy",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML with mutated NPM1, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation, previous cytotoxic therapy",
        "icc_classification": "AML with mutated NPM1, therapy related",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652208"
    },
    {
      "test_id": "test_000032",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "RUNX1::RUNX1T1": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "Cytotoxic chemotherapy"
        },
        "expected_difference": false
      },
      "who_classification": "AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy (WHO 2022)",
      "icc_classification": "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: RUNX1::RUNX1T1",
        "RUNX1::RUNX1T1 => AML with RUNX1::RUNX1T1 fusion",
        "No AML_differentiation provided.",
        "Detected WHO therapy => previous cytotoxic therapy: Cytotoxic chemotherapy",
        "No germline predisposition indicated (review at MDT)",
        "Classification with qualifiers => AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy",
        "Final classification => AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => RUNX1::RUNX1T1",
        "RUNX1::RUNX1T1 => AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1",
        "Detected ICC therapy => therapy related: Cytotoxic chemotherapy",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy",
        "icc_classification": "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652245"
    },
    {
      "test_id": "test_000033",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "qualifiers": {
          "previous_cytotoxic_therapy": "Cytotoxic chemotherapy"
        },
        "expected_difference": false
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy (WHO 2022)",
      "icc_classification": "AML, NOS, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "Detected WHO therapy => previous cytotoxic therapy: Cytotoxic chemotherapy",
        "No germline predisposition indicated (review at MDT)",
        "Classification with qualifiers => Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy",
        "Final classification => Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "Detected ICC therapy => therapy related: Cytotoxic chemotherapy",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML, NOS, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy",
        "icc_classification": "AML, NOS, therapy related",
        "who_category": "AML_THERAPY_RELATED",
        "icc_category": "AML_THERAPY_RELATED",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652286"
    },
    {
      "test_id": "test_000034",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "Any combination"
        },
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation, previous cytotoxic therapy (WHO 2022)",
      "icc_classification": "AML with mutated NPM1, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "Detected WHO therapy => previous cytotoxic therapy: Any combination",
        "No germline predisposition indicated (review at MDT)",
        "Classification with qualifiers => AML with NPM1 mutation, previous cytotoxic therapy",
        "Final classification => AML with NPM1 mutation, previous cytotoxic therapy (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "Detected ICC therapy => therapy related: Any combination",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML with mutated NPM1, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation, previous cytotoxic therapy",
        "icc_classification": "AML with mutated NPM1, therapy related",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652320"
    },
    {
      "test_id": "test_000035",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "RUNX1::RUNX1T1": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "Any combination"
        },
        "expected_difference": false
      },
      "who_classification": "AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy (WHO 2022)",
      "icc_classification": "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: RUNX1::RUNX1T1",
        "RUNX1::RUNX1T1 => AML with RUNX1::RUNX1T1 fusion",
        "No AML_differentiation provided.",
        "Detected WHO therapy => previous cytotoxic therapy: Any combination",
        "No germline predisposition indicated (review at MDT)",
        "Classification with qualifiers => AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy",
        "Final classification => AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => RUNX1::RUNX1T1",
        "RUNX1::RUNX1T1 => AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1",
        "Detected ICC therapy => therapy related: Any combination",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with RUNX1::RUNX1T1 fusion, previous cytotoxic therapy",
        "icc_classification": "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1, therapy related",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652358"
    },
    {
      "test_id": "test_000036",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "qualifiers": {
          "previous_cytotoxic_therapy": "Any combination"
        },
        "expected_difference": false
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy (WHO 2022)",
      "icc_classification": "AML, NOS, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "Detected WHO therapy => previous cytotoxic therapy: Any combination",
        "No germline predisposition indicated (review at MDT)",
        "Classification with qualifiers => Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy",
        "Final classification => Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "Detected ICC therapy => therapy related: Any combination",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => AML, NOS, therapy related (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation, previous cytotoxic therapy",
        "icc_classification": "AML, NOS, therapy related",
        "who_category": "AML_THERAPY_RELATED",
        "icc_category": "AML_THERAPY_RELATED",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652398"
    },
    {
      "test_id": "test_000037",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "None"
        },
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with NPM1 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated NPM1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation",
        "icc_classification": "AML with mutated NPM1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652418"
    },
    {
      "test_id": "test_000038",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "RUNX1::RUNX1T1": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "None"
        },
        "expected_difference": false
      },
      "who_classification": "AML with RUNX1::RUNX1T1 fusion (WHO 2022)",
      "icc_classification": "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: RUNX1::RUNX1T1",
        "RUNX1::RUNX1T1 => AML with RUNX1::RUNX1T1 fusion",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with RUNX1::RUNX1T1 fusion (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => RUNX1::RUNX1T1",
        "RUNX1::RUNX1T1 => AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with RUNX1::RUNX1T1 fusion",
        "icc_classification": "AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652443"
    },
    {
      "test_id": "test_000039",
      "input_data": {
        "blasts_percentage": 25.0,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "qualifiers": {
          "previous_cytotoxic_therapy": "None"
        },
        "expected_difference": false
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25.0",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "AML_NOS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "therapy_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652468"
    },
    {
      "test_id": "test_000040",
      "input_data": {
        "blasts_percentage": 30.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {
          "predisposing_germline_variant": "Diamond-Blackfan anemia"
        },
        "expected_difference": true
      },
      "who_classification": "AML with NPM1 mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1, in the setting of Diamond-Blackfan anemia (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 30.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "Final classification => AML with NPM1 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 30.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "Qualifier => in the setting of Diamond-Blackfan anemia",
        "Qualifiers appended => AML with mutated NPM1, in the setting of Diamond-Blackfan anemia (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation",
        "icc_classification": "AML with mutated NPM1, in the setting of Diamond-Blackfan anemia",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "germline_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652511"
    },
    {
      "test_id": "test_000041",
      "input_data": {
        "blasts_percentage": 30.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {
          "predisposing_germline_variant": "germline BLM mutation"
        },
        "expected_difference": true
      },
      "who_classification": "AML with NPM1 mutation, associated with germline BLM mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 30.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "Detected germline predisposition => associated with germline BLM mutation",
        "Classification with qualifiers => AML with NPM1 mutation, associated with germline BLM mutation",
        "Final classification => AML with NPM1 mutation, associated with germline BLM mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 30.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "Final => AML with mutated NPM1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation, associated with germline BLM mutation",
        "icc_classification": "AML with mutated NPM1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "germline_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652548"
    },
    {
      "test_id": "test_000042",
      "input_data": {
        "blasts_percentage": 30.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {
          "predisposing_germline_variant": "germline CEBPA mutation"
        },
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation, associated with germline CEBPA mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1, in the setting of germline CEBPA mutation (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 30.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "Detected germline predisposition => associated with germline CEBPA mutation",
        "Classification with qualifiers => AML with NPM1 mutation, associated with germline CEBPA mutation",
        "Final classification => AML with NPM1 mutation, associated with germline CEBPA mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 30.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "Qualifier => in the setting of germline CEBPA mutation",
        "Qualifiers appended => AML with mutated NPM1, in the setting of germline CEBPA mutation (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation, associated with germline CEBPA mutation",
        "icc_classification": "AML with mutated NPM1, in the setting of germline CEBPA mutation",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "germline_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652589"
    },
    {
      "test_id": "test_000043",
      "input_data": {
        "blasts_percentage": 30.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {
          "predisposing_germline_variant": "germline DDX41 mutation"
        },
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation, associated with germline DDX41 mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1, in the setting of germline DDX41 mutation (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 30.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "Detected germline predisposition => associated with germline DDX41 mutation",
        "Classification with qualifiers => AML with NPM1 mutation, associated with germline DDX41 mutation",
        "Final classification => AML with NPM1 mutation, associated with germline DDX41 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 30.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "Qualifier => in the setting of germline DDX41 mutation",
        "Qualifiers appended => AML with mutated NPM1, in the setting of germline DDX41 mutation (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation, associated with germline DDX41 mutation",
        "icc_classification": "AML with mutated NPM1, in the setting of germline DDX41 mutation",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "germline_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652630"
    },
    {
      "test_id": "test_000044",
      "input_data": {
        "blasts_percentage": 30.0,
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true
        },
        "qualifiers": {
          "predisposing_germline_variant": "Fanconi anaemia"
        },
        "expected_difference": false
      },
      "who_classification": "AML with NPM1 mutation, associated with Fanconi anaemia (WHO 2022)",
      "icc_classification": "AML with mutated NPM1, in the setting of Fanconi anaemia (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 30.0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "Detected germline predisposition => associated with Fanconi anaemia",
        "Classification with qualifiers => AML with NPM1 mutation, associated with Fanconi anaemia",
        "Final classification => AML with NPM1 mutation, associated with Fanconi anaemia (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 30.0",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1",
        "NPM1 => AML with mutated NPM1",
        "Qualifier => in the setting of Fanconi anaemia",
        "Qualifiers appended => AML with mutated NPM1, in the setting of Fanconi anaemia (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation, associated with Fanconi anaemia",
        "icc_classification": "AML with mutated NPM1, in the setting of Fanconi anaemia",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "germline_qualifiers",
      "timestamp": "2025-06-06T19:25:13.652670"
    },
    {
      "test_id": "test_000045",
      "input_data": {
        "blasts_percentage": 5,
        "Biallelic_TP53_mutation": {
          "2_x_TP53_mutations": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'2_x_TP53_mutations': True}",
        "TP53 conditions: 2 mutations: True, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: True, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with mutated TP53"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.652698"
    },
    {
      "test_id": "test_000046",
      "input_data": {
        "blasts_percentage": 10,
        "Biallelic_TP53_mutation": {
          "2_x_TP53_mutations": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'2_x_TP53_mutations': True}",
        "TP53 conditions: 2 mutations: True, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.652737"
    },
    {
      "test_id": "test_000047",
      "input_data": {
        "blasts_percentage": 15,
        "Biallelic_TP53_mutation": {
          "2_x_TP53_mutations": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'2_x_TP53_mutations': True}",
        "TP53 conditions: 2 mutations: True, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.652772"
    },
    {
      "test_id": "test_000048",
      "input_data": {
        "blasts_percentage": 20,
        "Biallelic_TP53_mutation": {
          "2_x_TP53_mutations": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML with mutated TP53",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.652811"
    },
    {
      "test_id": "test_000049",
      "input_data": {
        "blasts_percentage": 25,
        "Biallelic_TP53_mutation": {
          "2_x_TP53_mutations": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML with mutated TP53",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.652848"
    },
    {
      "test_id": "test_000050",
      "input_data": {
        "blasts_percentage": 5,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_del_17p": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_del_17p': True}",
        "TP53 conditions: 2 mutations: False, with del17p: True, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: True, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with mutated TP53"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.652873"
    },
    {
      "test_id": "test_000051",
      "input_data": {
        "blasts_percentage": 10,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_del_17p": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_del_17p': True}",
        "TP53 conditions: 2 mutations: False, with del17p: True, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.652915"
    },
    {
      "test_id": "test_000052",
      "input_data": {
        "blasts_percentage": 15,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_del_17p": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_del_17p': True}",
        "TP53 conditions: 2 mutations: False, with del17p: True, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.652949"
    },
    {
      "test_id": "test_000053",
      "input_data": {
        "blasts_percentage": 20,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_del_17p": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML with mutated TP53",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.652985"
    },
    {
      "test_id": "test_000054",
      "input_data": {
        "blasts_percentage": 25,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_del_17p": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML with mutated TP53",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653021"
    },
    {
      "test_id": "test_000055",
      "input_data": {
        "blasts_percentage": 5,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_LOH": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_LOH': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: True, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: True, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with mutated TP53"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653044"
    },
    {
      "test_id": "test_000056",
      "input_data": {
        "blasts_percentage": 10,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_LOH": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_LOH': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: True, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653081"
    },
    {
      "test_id": "test_000057",
      "input_data": {
        "blasts_percentage": 15,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_LOH": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_LOH': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: True, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653115"
    },
    {
      "test_id": "test_000058",
      "input_data": {
        "blasts_percentage": 20,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_LOH": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML with mutated TP53",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653151"
    },
    {
      "test_id": "test_000059",
      "input_data": {
        "blasts_percentage": 25,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_LOH": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML with mutated TP53",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653186"
    },
    {
      "test_id": "test_000060",
      "input_data": {
        "blasts_percentage": 5,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_50_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_50_percent_vaf': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: True, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: True, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with mutated TP53"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653210"
    },
    {
      "test_id": "test_000061",
      "input_data": {
        "blasts_percentage": 10,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_50_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_50_percent_vaf': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: True, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653248"
    },
    {
      "test_id": "test_000062",
      "input_data": {
        "blasts_percentage": 15,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_50_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_50_percent_vaf': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: True, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653283"
    },
    {
      "test_id": "test_000063",
      "input_data": {
        "blasts_percentage": 20,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_50_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "AML_NOS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653306"
    },
    {
      "test_id": "test_000064",
      "input_data": {
        "blasts_percentage": 25,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_50_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "AML_NOS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653330"
    },
    {
      "test_id": "test_000065",
      "input_data": {
        "blasts_percentage": 5,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_10_percent_vaf': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 5, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 5",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653358"
    },
    {
      "test_id": "test_000066",
      "input_data": {
        "blasts_percentage": 5,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "Complex_karyotype": true
        },
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_10_percent_vaf': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: True",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: True",
        "Biallelic TP53 detected => MDS with mutated TP53"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653384"
    },
    {
      "test_id": "test_000067",
      "input_data": {
        "blasts_percentage": 10,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_10_percent_vaf': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 10, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_TP53",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653423"
    },
    {
      "test_id": "test_000068",
      "input_data": {
        "blasts_percentage": 10,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "Complex_karyotype": true
        },
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_10_percent_vaf': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: True",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653457"
    },
    {
      "test_id": "test_000069",
      "input_data": {
        "blasts_percentage": 15,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_10_percent_vaf': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_TP53",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653496"
    },
    {
      "test_id": "test_000070",
      "input_data": {
        "blasts_percentage": 15,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "Complex_karyotype": true
        },
        "qualifiers": {}
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_10_percent_vaf': True}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: True",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653531"
    },
    {
      "test_id": "test_000071",
      "input_data": {
        "blasts_percentage": 20,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML with mutated TP53",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653567"
    },
    {
      "test_id": "test_000072",
      "input_data": {
        "blasts_percentage": 20,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "Complex_karyotype": true
        },
        "qualifiers": {}
      },
      "who_classification": "AML, myelodysplasia related (WHO 2022)",
      "icc_classification": "AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "MDS-related cytogenetic(s): Complex_karyotype => AML, myelodysplasia related",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML, myelodysplasia related (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "AML, myelodysplasia related",
        "icc_classification": "AML with mutated TP53",
        "who_category": "AML_MDS_RELATED",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "diagnostic_uncertainty",
        "significance": "high"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653606"
    },
    {
      "test_id": "test_000073",
      "input_data": {
        "blasts_percentage": 25,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML with mutated TP53",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653642"
    },
    {
      "test_id": "test_000074",
      "input_data": {
        "blasts_percentage": 25,
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "Complex_karyotype": true
        },
        "qualifiers": {}
      },
      "who_classification": "AML, myelodysplasia related (WHO 2022)",
      "icc_classification": "AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "MDS-related cytogenetic(s): Complex_karyotype => AML, myelodysplasia related",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML, myelodysplasia related (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "AML, myelodysplasia related",
        "icc_classification": "AML with mutated TP53",
        "who_category": "AML_MDS_RELATED",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "diagnostic_uncertainty",
        "significance": "high"
      },
      "test_focus": "tp53_terminology",
      "timestamp": "2025-06-06T19:25:13.653678"
    },
    {
      "test_id": "test_000075",
      "input_data": {
        "blasts_percentage": 4,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS, unclassifiable (WHO 2022)",
      "icc_classification": "MDS, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 4, fibrotic: False",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, unclassifiable (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 4",
        "number_of_dysplastic_lineages: None",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS, unclassifiable",
        "icc_classification": "MDS, NOS",
        "who_category": "MDS_NOS",
        "icc_category": "MDS_NOS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653706"
    },
    {
      "test_id": "test_000076",
      "input_data": {
        "blasts_percentage": 4,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {
          "SF3B1": true
        },
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with low blasts and SF3B1 (WHO 2022)",
      "icc_classification": "MDS with mutated SF3B1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 4, fibrotic: False",
        "SF3B1 mutation detected => MDS with low blasts and SF3B1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with low blasts and SF3B1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "MDS-related genes => AML with myelodysplasia related gene mutation",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 4",
        "SF3B1 mutation detected => MDS with mutated SF3B1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with mutated SF3B1 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with low blasts and SF3B1",
        "icc_classification": "MDS with mutated SF3B1",
        "who_category": "MDS_SF3B1",
        "icc_category": "MDS_SF3B1",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653733"
    },
    {
      "test_id": "test_000077",
      "input_data": {
        "blasts_percentage": 4,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "del_5q": true
        },
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with low blasts and isolated 5q- (WHO 2022)",
      "icc_classification": "MDS with del(5q) (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 4, fibrotic: False",
        "del(5q) detected => MDS with low blasts and isolated 5q-",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with low blasts and isolated 5q- (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "MDS-related cyto => AML with myelodysplasia related cytogenetic abnormality",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 4",
        "del(5q) detected => MDS with del(5q)",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with del(5q) (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with low blasts and isolated 5q-",
        "icc_classification": "MDS with del(5q)",
        "who_category": "MDS_5Q",
        "icc_category": "MDS_5Q",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653761"
    },
    {
      "test_id": "test_000078",
      "input_data": {
        "blasts_percentage": 4,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "number_of_dysplastic_lineages": 2
      },
      "who_classification": "MDS with low blasts (WHO 2022)",
      "icc_classification": "MDS, NOS with multilineage dysplasia (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 4, fibrotic: False",
        "Multiple dysplastic lineages => MDS with low blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with low blasts (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 4",
        "number_of_dysplastic_lineages: 2",
        "Multilineage dysplasia => MDS, NOS with multilineage dysplasia",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, NOS with multilineage dysplasia (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with low blasts",
        "icc_classification": "MDS, NOS with multilineage dysplasia",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_DYSPLASIA",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653803"
    },
    {
      "test_id": "test_000079",
      "input_data": {
        "blasts_percentage": 4,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "fibrotic": true
      },
      "who_classification": "MDS, unclassifiable (WHO 2022)",
      "icc_classification": "MDS, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 4, fibrotic: True",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, unclassifiable (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 4",
        "number_of_dysplastic_lineages: None",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS, unclassifiable",
        "icc_classification": "MDS, NOS",
        "who_category": "MDS_NOS",
        "icc_category": "MDS_NOS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653828"
    },
    {
      "test_id": "test_000080",
      "input_data": {
        "blasts_percentage": 4,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "hypoplasia": true
      },
      "who_classification": "MDS, hypoplastic (WHO 2022)",
      "icc_classification": "MDS, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 4, fibrotic: False",
        "Hypoplasia detected => MDS, hypoplastic",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, hypoplastic (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 4",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 4",
        "number_of_dysplastic_lineages: None",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS, hypoplastic",
        "icc_classification": "MDS, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "MDS_NOS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653852"
    },
    {
      "test_id": "test_000081",
      "input_data": {
        "blasts_percentage": 5,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 5, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 5",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653877"
    },
    {
      "test_id": "test_000082",
      "input_data": {
        "blasts_percentage": 5,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {
          "SF3B1": true
        },
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 5, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "MDS-related genes => AML with myelodysplasia related gene mutation",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 5",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653902"
    },
    {
      "test_id": "test_000083",
      "input_data": {
        "blasts_percentage": 5,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "del_5q": true
        },
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 5, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "MDS-related cyto => AML with myelodysplasia related cytogenetic abnormality",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 5",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653928"
    },
    {
      "test_id": "test_000084",
      "input_data": {
        "blasts_percentage": 5,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "number_of_dysplastic_lineages": 2
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 5, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 5",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653952"
    },
    {
      "test_id": "test_000085",
      "input_data": {
        "blasts_percentage": 5,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "fibrotic": true
      },
      "who_classification": "MDS, fibrotic (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 5, fibrotic: True",
        "5-9% blasts => MDS with increased blasts 1",
        "Blasts 5-19% with fibrotic marrow => MDS, fibrotic",
        "Current classification: MDS, fibrotic",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, fibrotic (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 5",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS, fibrotic",
        "icc_classification": "MDS with excess blasts",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.653976"
    },
    {
      "test_id": "test_000086",
      "input_data": {
        "blasts_percentage": 5,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "hypoplasia": true
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 5, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 5",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 5",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654002"
    },
    {
      "test_id": "test_000087",
      "input_data": {
        "blasts_percentage": 8,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 8, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 8",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654026"
    },
    {
      "test_id": "test_000088",
      "input_data": {
        "blasts_percentage": 8,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {
          "SF3B1": true
        },
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 8, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "MDS-related genes => AML with myelodysplasia related gene mutation",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 8",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654052"
    },
    {
      "test_id": "test_000089",
      "input_data": {
        "blasts_percentage": 8,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "del_5q": true
        },
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 8, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "MDS-related cyto => AML with myelodysplasia related cytogenetic abnormality",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 8",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654076"
    },
    {
      "test_id": "test_000090",
      "input_data": {
        "blasts_percentage": 8,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "number_of_dysplastic_lineages": 2
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 8, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 8",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654100"
    },
    {
      "test_id": "test_000091",
      "input_data": {
        "blasts_percentage": 8,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "fibrotic": true
      },
      "who_classification": "MDS, fibrotic (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 8, fibrotic: True",
        "5-9% blasts => MDS with increased blasts 1",
        "Blasts 5-19% with fibrotic marrow => MDS, fibrotic",
        "Current classification: MDS, fibrotic",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, fibrotic (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 8",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS, fibrotic",
        "icc_classification": "MDS with excess blasts",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654123"
    },
    {
      "test_id": "test_000092",
      "input_data": {
        "blasts_percentage": 8,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "hypoplasia": true
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 8, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 8",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654147"
    },
    {
      "test_id": "test_000093",
      "input_data": {
        "blasts_percentage": 9,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 9, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 9",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654173"
    },
    {
      "test_id": "test_000094",
      "input_data": {
        "blasts_percentage": 9,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {
          "SF3B1": true
        },
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 9, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "MDS-related genes => AML with myelodysplasia related gene mutation",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 9",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654197"
    },
    {
      "test_id": "test_000095",
      "input_data": {
        "blasts_percentage": 9,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "del_5q": true
        },
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 9, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "MDS-related cyto => AML with myelodysplasia related cytogenetic abnormality",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 9",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654221"
    },
    {
      "test_id": "test_000096",
      "input_data": {
        "blasts_percentage": 9,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "number_of_dysplastic_lineages": 2
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 9, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 9",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654245"
    },
    {
      "test_id": "test_000097",
      "input_data": {
        "blasts_percentage": 9,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "fibrotic": true
      },
      "who_classification": "MDS, fibrotic (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 9, fibrotic: True",
        "5-9% blasts => MDS with increased blasts 1",
        "Blasts 5-19% with fibrotic marrow => MDS, fibrotic",
        "Current classification: MDS, fibrotic",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, fibrotic (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 9",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS, fibrotic",
        "icc_classification": "MDS with excess blasts",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654269"
    },
    {
      "test_id": "test_000098",
      "input_data": {
        "blasts_percentage": 9,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "hypoplasia": true
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 9, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 9",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 9",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654293"
    },
    {
      "test_id": "test_000099",
      "input_data": {
        "blasts_percentage": 10,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 10, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654331"
    },
    {
      "test_id": "test_000100",
      "input_data": {
        "blasts_percentage": 10,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {
          "SF3B1": true
        },
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML with myelodysplasia related gene mutation (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 10, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "MDS-related genes => AML with myelodysplasia related gene mutation",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with myelodysplasia related gene mutation",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with myelodysplasia related gene mutation (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML with myelodysplasia related gene mutation",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_MDS_RELATED",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654373"
    },
    {
      "test_id": "test_000101",
      "input_data": {
        "blasts_percentage": 10,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "del_5q": true
        },
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML with myelodysplasia related cytogenetic abnormality (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 10, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "MDS-related cyto => AML with myelodysplasia related cytogenetic abnormality",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with myelodysplasia related cytogenetic abnormality",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with myelodysplasia related cytogenetic abnormality (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML with myelodysplasia related cytogenetic abnormality",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_MDS_RELATED",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654422"
    },
    {
      "test_id": "test_000102",
      "input_data": {
        "blasts_percentage": 10,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "number_of_dysplastic_lineages": 2
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 10, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654457"
    },
    {
      "test_id": "test_000103",
      "input_data": {
        "blasts_percentage": 10,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "fibrotic": true
      },
      "who_classification": "MDS, fibrotic (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 10, fibrotic: True",
        "10-19% blasts => MDS with increased blasts 2",
        "Blasts 5-19% with fibrotic marrow => MDS, fibrotic",
        "Current classification: MDS, fibrotic",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, fibrotic (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS, fibrotic",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "diagnostic_uncertainty",
        "significance": "high"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654492"
    },
    {
      "test_id": "test_000104",
      "input_data": {
        "blasts_percentage": 10,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "hypoplasia": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 10, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 10",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654527"
    },
    {
      "test_id": "test_000105",
      "input_data": {
        "blasts_percentage": 15,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654561"
    },
    {
      "test_id": "test_000106",
      "input_data": {
        "blasts_percentage": 15,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {
          "SF3B1": true
        },
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML with myelodysplasia related gene mutation (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "MDS-related genes => AML with myelodysplasia related gene mutation",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with myelodysplasia related gene mutation",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with myelodysplasia related gene mutation (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML with myelodysplasia related gene mutation",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_MDS_RELATED",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654600"
    },
    {
      "test_id": "test_000107",
      "input_data": {
        "blasts_percentage": 15,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "del_5q": true
        },
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML with myelodysplasia related cytogenetic abnormality (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "MDS-related cyto => AML with myelodysplasia related cytogenetic abnormality",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with myelodysplasia related cytogenetic abnormality",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with myelodysplasia related cytogenetic abnormality (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML with myelodysplasia related cytogenetic abnormality",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_MDS_RELATED",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654640"
    },
    {
      "test_id": "test_000108",
      "input_data": {
        "blasts_percentage": 15,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "number_of_dysplastic_lineages": 2
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654674"
    },
    {
      "test_id": "test_000109",
      "input_data": {
        "blasts_percentage": 15,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "fibrotic": true
      },
      "who_classification": "MDS, fibrotic (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: True",
        "10-19% blasts => MDS with increased blasts 2",
        "Blasts 5-19% with fibrotic marrow => MDS, fibrotic",
        "Current classification: MDS, fibrotic",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, fibrotic (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS, fibrotic",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "diagnostic_uncertainty",
        "significance": "high"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654710"
    },
    {
      "test_id": "test_000110",
      "input_data": {
        "blasts_percentage": 15,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "hypoplasia": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654746"
    },
    {
      "test_id": "test_000111",
      "input_data": {
        "blasts_percentage": 19,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 19, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654781"
    },
    {
      "test_id": "test_000112",
      "input_data": {
        "blasts_percentage": 19,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {
          "SF3B1": true
        },
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML with myelodysplasia related gene mutation (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 19, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "MDS-related genes => AML with myelodysplasia related gene mutation",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with myelodysplasia related gene mutation",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with myelodysplasia related gene mutation (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML with myelodysplasia related gene mutation",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_MDS_RELATED",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654864"
    },
    {
      "test_id": "test_000113",
      "input_data": {
        "blasts_percentage": 19,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "del_5q": true
        },
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML with myelodysplasia related cytogenetic abnormality (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 19, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "MDS-related cyto => AML with myelodysplasia related cytogenetic abnormality",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with myelodysplasia related cytogenetic abnormality",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with myelodysplasia related cytogenetic abnormality (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML with myelodysplasia related cytogenetic abnormality",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_MDS_RELATED",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654905"
    },
    {
      "test_id": "test_000114",
      "input_data": {
        "blasts_percentage": 19,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "number_of_dysplastic_lineages": 2
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 19, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654941"
    },
    {
      "test_id": "test_000115",
      "input_data": {
        "blasts_percentage": 19,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "fibrotic": true
      },
      "who_classification": "MDS, fibrotic (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 19, fibrotic: True",
        "10-19% blasts => MDS with increased blasts 2",
        "Blasts 5-19% with fibrotic marrow => MDS, fibrotic",
        "Current classification: MDS, fibrotic",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, fibrotic (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS, fibrotic",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "diagnostic_uncertainty",
        "significance": "high"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.654975"
    },
    {
      "test_id": "test_000116",
      "input_data": {
        "blasts_percentage": 19,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "hypoplasia": true
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 19, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 19",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.655009"
    },
    {
      "test_id": "test_000117",
      "input_data": {
        "blasts_percentage": 20,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "AML_NOS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.655033"
    },
    {
      "test_id": "test_000118",
      "input_data": {
        "blasts_percentage": 20,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {
          "SF3B1": true
        },
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "AML, myelodysplasia related (WHO 2022)",
      "icc_classification": "AML with myelodysplasia related gene mutation (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "MDS-related mutation(s): SF3B1 => AML, myelodysplasia related",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML, myelodysplasia related (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "MDS-related genes => AML with myelodysplasia related gene mutation",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with myelodysplasia related gene mutation (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML, myelodysplasia related",
        "icc_classification": "AML with myelodysplasia related gene mutation",
        "who_category": "AML_MDS_RELATED",
        "icc_category": "AML_MDS_RELATED",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.655059"
    },
    {
      "test_id": "test_000119",
      "input_data": {
        "blasts_percentage": 20,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {
          "del_5q": true
        },
        "Biallelic_TP53_mutation": {},
        "qualifiers": {}
      },
      "who_classification": "AML, myelodysplasia related (WHO 2022)",
      "icc_classification": "AML with myelodysplasia related cytogenetic abnormality (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "MDS-related cytogenetic(s): del_5q => AML, myelodysplasia related",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML, myelodysplasia related (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "MDS-related cyto => AML with myelodysplasia related cytogenetic abnormality",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with myelodysplasia related cytogenetic abnormality (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML, myelodysplasia related",
        "icc_classification": "AML with myelodysplasia related cytogenetic abnormality",
        "who_category": "AML_MDS_RELATED",
        "icc_category": "AML_MDS_RELATED",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.655102"
    },
    {
      "test_id": "test_000120",
      "input_data": {
        "blasts_percentage": 20,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "number_of_dysplastic_lineages": 2
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "AML_NOS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.655125"
    },
    {
      "test_id": "test_000121",
      "input_data": {
        "blasts_percentage": 20,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "fibrotic": true
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "AML_NOS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.655147"
    },
    {
      "test_id": "test_000122",
      "input_data": {
        "blasts_percentage": 20,
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "hypoplasia": true
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "AML_NOS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "mds_blast_ranges",
      "timestamp": "2025-06-06T19:25:13.655169"
    },
    {
      "test_id": "test_000123",
      "input_data": {
        "blasts_percentage": 15,
        "AML_differentiation": "M6a",
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute Erythroid leukaemia (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "AML_differentiation: M6a",
        "Erythroid subtype => Acute Erythroid leukaemia",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute Erythroid leukaemia (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "Acute Erythroid leukaemia",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "AML_ERYTHROID",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "erythroid_handling",
      "timestamp": "2025-06-06T19:25:13.655203"
    },
    {
      "test_id": "test_000124",
      "input_data": {
        "blasts_percentage": 20,
        "AML_differentiation": "M6a",
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute Erythroid leukaemia (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "AML_differentiation: M6a",
        "Erythroid subtype => Acute Erythroid leukaemia",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute Erythroid leukaemia (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "Acute Erythroid leukaemia",
        "icc_classification": "AML, NOS",
        "who_category": "AML_ERYTHROID",
        "icc_category": "AML_NOS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "erythroid_handling",
      "timestamp": "2025-06-06T19:25:13.655234"
    },
    {
      "test_id": "test_000125",
      "input_data": {
        "blasts_percentage": 25,
        "AML_differentiation": "M6a",
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute Erythroid leukaemia (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "AML_differentiation: M6a",
        "Erythroid subtype => Acute Erythroid leukaemia",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute Erythroid leukaemia (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "Acute Erythroid leukaemia",
        "icc_classification": "AML, NOS",
        "who_category": "AML_ERYTHROID",
        "icc_category": "AML_NOS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "erythroid_handling",
      "timestamp": "2025-06-06T19:25:13.655265"
    },
    {
      "test_id": "test_000126",
      "input_data": {
        "blasts_percentage": 30,
        "AML_differentiation": "M6a",
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute Erythroid leukaemia (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 30",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "AML_differentiation: M6a",
        "Erythroid subtype => Acute Erythroid leukaemia",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute Erythroid leukaemia (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 30",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "Acute Erythroid leukaemia",
        "icc_classification": "AML, NOS",
        "who_category": "AML_ERYTHROID",
        "icc_category": "AML_NOS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "erythroid_handling",
      "timestamp": "2025-06-06T19:25:13.655295"
    },
    {
      "test_id": "test_000127",
      "input_data": {
        "blasts_percentage": 15,
        "AML_differentiation": "M6b",
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute Erythroid leukaemia (WHO 2022)",
      "icc_classification": "MDS/AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "AML_differentiation: M6b",
        "Erythroid subtype => Acute Erythroid leukaemia",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute Erythroid leukaemia (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "Acute Erythroid leukaemia",
        "icc_classification": "MDS/AML, NOS",
        "who_category": "AML_ERYTHROID",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "erythroid_handling",
      "timestamp": "2025-06-06T19:25:13.655326"
    },
    {
      "test_id": "test_000128",
      "input_data": {
        "blasts_percentage": 20,
        "AML_differentiation": "M6b",
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute Erythroid leukaemia (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "AML_differentiation: M6b",
        "Erythroid subtype => Acute Erythroid leukaemia",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute Erythroid leukaemia (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "Acute Erythroid leukaemia",
        "icc_classification": "AML, NOS",
        "who_category": "AML_ERYTHROID",
        "icc_category": "AML_NOS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "erythroid_handling",
      "timestamp": "2025-06-06T19:25:13.655356"
    },
    {
      "test_id": "test_000129",
      "input_data": {
        "blasts_percentage": 25,
        "AML_differentiation": "M6b",
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute Erythroid leukaemia (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "AML_differentiation: M6b",
        "Erythroid subtype => Acute Erythroid leukaemia",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute Erythroid leukaemia (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "Acute Erythroid leukaemia",
        "icc_classification": "AML, NOS",
        "who_category": "AML_ERYTHROID",
        "icc_category": "AML_NOS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "erythroid_handling",
      "timestamp": "2025-06-06T19:25:13.655386"
    },
    {
      "test_id": "test_000130",
      "input_data": {
        "blasts_percentage": 30,
        "AML_differentiation": "M6b",
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "qualifiers": {}
      },
      "who_classification": "Acute Erythroid leukaemia (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 30",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "AML_differentiation: M6b",
        "Erythroid subtype => Acute Erythroid leukaemia",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute Erythroid leukaemia (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 30",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "Acute Erythroid leukaemia",
        "icc_classification": "AML, NOS",
        "who_category": "AML_ERYTHROID",
        "icc_category": "AML_NOS",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "erythroid_handling",
      "timestamp": "2025-06-06T19:25:13.655417"
    },
    {
      "test_id": "test_000131",
      "input_data": {
        "AML_defining_recurrent_genetic_abnormalities": {
          "CEBPA": true
        },
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {
          "previous_cytotoxic_therapy": "Immune interventions"
        },
        "blasts_percentage": 15
      },
      "who_classification": "MDS with increased blasts 2 (WHO 2022)",
      "icc_classification": "MDS/AML, NOS, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: CEBPA",
        "CEBPA found but blasts <20 => not AML by this route",
        "No AML-defining abnormality fully matched, blasts <20 => consider MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 15, fibrotic: False",
        "10-19% blasts => MDS with increased blasts 2",
        "Current classification: MDS with increased blasts 2",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 2 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => CEBPA",
        "No single ICC AML-def abnormality triggered classification.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML, NOS",
        "Detected ICC therapy => therapy related: Immune interventions",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => MDS/AML, NOS, therapy related (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 2",
        "icc_classification": "MDS/AML, NOS, therapy related",
        "who_category": "MDS_BLASTS",
        "icc_category": "AML_THERAPY_RELATED",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "combination_scenarios",
      "timestamp": "2025-06-06T19:25:13.655461"
    },
    {
      "test_id": "test_000132",
      "input_data": {
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {
          "2_x_TP53_mutations": true
        },
        "qualifiers": {
          "predisposing_germline_variant": "Diamond-Blackfan anemia"
        },
        "blasts_percentage": 20
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML with mutated TP53, in the setting of Diamond-Blackfan anemia (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 20",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts >=20 => remain AML",
        "Qualifier => in the setting of Diamond-Blackfan anemia",
        "Qualifiers appended => AML with mutated TP53, in the setting of Diamond-Blackfan anemia (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML with mutated TP53, in the setting of Diamond-Blackfan anemia",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "UNCLASSIFIABLE",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "combination_scenarios",
      "timestamp": "2025-06-06T19:25:13.655512"
    },
    {
      "test_id": "test_000133",
      "input_data": {
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {
          "1_x_TP53_mutation_del_17p": true
        },
        "qualifiers": {
          "previous_cytotoxic_therapy": "Immune interventions"
        },
        "blasts_percentage": 12
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53, therapy related (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 12",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'1_x_TP53_mutation_del_17p': True}",
        "TP53 conditions: 2 mutations: False, with del17p: True, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 12",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "Detected ICC therapy => therapy related: Immune interventions",
        "No germline predisposition indicated (review at MDT)",
        "Qualifiers appended => MDS/AML with mutated TP53, therapy related (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": false,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML with mutated TP53, therapy related",
        "who_category": "MDS_TP53",
        "icc_category": "AML_THERAPY_RELATED",
        "are_equivalent": false,
        "category_match": false,
        "difference_type": "category_difference",
        "significance": "medium"
      },
      "test_focus": "combination_scenarios",
      "timestamp": "2025-06-06T19:25:13.655554"
    },
    {
      "test_id": "test_000134",
      "input_data": {
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {
          "ASXL1": true,
          "SF3B1": true
        },
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "blasts_percentage": 25,
        "AML_differentiation": "M6a"
      },
      "who_classification": "AML, myelodysplasia related (WHO 2022)",
      "icc_classification": "AML with myelodysplasia related gene mutation (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "MDS-related mutation(s): ASXL1, SF3B1 => AML, myelodysplasia related",
        "AML_differentiation: M6a",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML, myelodysplasia related (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "MDS-related genes => AML with myelodysplasia related gene mutation",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with myelodysplasia related gene mutation (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML, myelodysplasia related",
        "icc_classification": "AML with myelodysplasia related gene mutation",
        "who_category": "AML_MDS_RELATED",
        "icc_category": "AML_MDS_RELATED",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "combination_scenarios",
      "timestamp": "2025-06-06T19:25:13.655580"
    },
    {
      "test_id": "test_000135",
      "input_data": {
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "blasts_percentage": 0
      },
      "who_classification": "MDS, unclassifiable (WHO 2022)",
      "icc_classification": "MDS, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 0",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 0, fibrotic: False",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, unclassifiable (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 0",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 0",
        "number_of_dysplastic_lineages: None",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS, NOS (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS, unclassifiable",
        "icc_classification": "MDS, NOS",
        "who_category": "MDS_NOS",
        "icc_category": "MDS_NOS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "edge_cases",
      "timestamp": "2025-06-06T19:25:13.655606"
    },
    {
      "test_id": "test_000136",
      "input_data": {
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "blasts_percentage": 100
      },
      "who_classification": "Acute myeloid leukaemia, unknown differentiation (WHO 2022)",
      "icc_classification": "AML, NOS (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 100",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No MDS-related mutations found.",
        "No MDS-related cytogenetic flags found.",
        "No AML_differentiation provided.",
        "No valid AML_differentiation => unknown differentiation",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Acute myeloid leukaemia, unknown differentiation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 100",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "No MDS-related genes set to True.",
        "No MDS-related cytogenetics triggered classification.",
        "Blasts >=20 => remain AML",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML, NOS (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "Acute myeloid leukaemia, unknown differentiation",
        "icc_classification": "AML, NOS",
        "who_category": "UNCLASSIFIABLE",
        "icc_category": "AML_NOS",
        "are_equivalent": true,
        "category_match": false,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "edge_cases",
      "timestamp": "2025-06-06T19:25:13.655629"
    },
    {
      "test_id": "test_000137",
      "input_data": {
        "AML_defining_recurrent_genetic_abnormalities": {
          "NPM1": true,
          "RUNX1::RUNX1T1": true,
          "CBFB::MYH11": true
        },
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "blasts_percentage": 25
      },
      "who_classification": "AML with NPM1 mutation (WHO 2022)",
      "icc_classification": "AML with mutated NPM1 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "Detected AML-defining abnormality flags: NPM1, RUNX1::RUNX1T1, CBFB::MYH11",
        "NPM1 => AML with NPM1 mutation",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => AML with NPM1 mutation (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 25",
        "Default classification set to: AML, NOS",
        "ICC AML-defining flags => NPM1, RUNX1::RUNX1T1, CBFB::MYH11",
        "NPM1 => AML with mutated NPM1",
        "No germline predisposition indicated (review at MDT)",
        "Final => AML with mutated NPM1 (ICC 2022)"
      ],
      "who_disease_type": "AML",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "AML with NPM1 mutation",
        "icc_classification": "AML with mutated NPM1",
        "who_category": "AML_GENETIC",
        "icc_category": "AML_GENETIC",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "edge_cases",
      "timestamp": "2025-06-06T19:25:13.655652"
    },
    {
      "test_id": "test_000138",
      "input_data": {
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {
          "ASXL1": true,
          "RUNX1": true,
          "SF3B1": true,
          "SRSF2": true,
          "U2AF1": true,
          "EZH2": true
        },
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {},
        "qualifiers": {},
        "blasts_percentage": 8
      },
      "who_classification": "MDS with increased blasts 1 (WHO 2022)",
      "icc_classification": "MDS with excess blasts (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {}",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "Retrieved blasts: 8, fibrotic: False",
        "5-9% blasts => MDS with increased blasts 1",
        "Current classification: MDS with increased blasts 1",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with increased blasts 1 (WHO 2022)"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 8",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "No biallelic TP53 conditions met.",
        "MDS-related genes => AML with myelodysplasia related gene mutation",
        "Blasts <10 => final classification: Not AML, consider MDS classification",
        "No germline predisposition indicated (review at MDT)",
        "Final => Not AML, consider MDS classification",
        "AML ICC classifier indicated that the case is not AML. Switching to MDS ICC classification...",
        "Default classification set to: MDS, NOS",
        "TP53 conditions: 2 mutations: False, with del17p: False, with LOH: False, with \u226550% VAF: False, with \u226510% VAF + complex karyotype: False",
        "blasts_percentage: 8",
        "5-9% blasts => MDS with excess blasts",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => MDS with excess blasts (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "MDS",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with increased blasts 1",
        "icc_classification": "MDS with excess blasts",
        "who_category": "MDS_BLASTS",
        "icc_category": "MDS_BLASTS",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "edge_cases",
      "timestamp": "2025-06-06T19:25:13.655678"
    },
    {
      "test_id": "test_000139",
      "input_data": {
        "AML_defining_recurrent_genetic_abnormalities": {},
        "MDS_related_mutation": {},
        "MDS_related_cytogenetics": {},
        "Biallelic_TP53_mutation": {
          "2_x_TP53_mutations": true,
          "1_x_TP53_mutation_del_17p": true,
          "1_x_TP53_mutation_LOH": true,
          "1_x_TP53_mutation_50_percent_vaf": true,
          "1_x_TP53_mutation_10_percent_vaf": true
        },
        "qualifiers": {},
        "blasts_percentage": 15
      },
      "who_classification": "MDS with biallelic TP53 inactivation (WHO 2022)",
      "icc_classification": "MDS/AML with mutated TP53 (ICC 2022)",
      "who_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: Acute myeloid leukaemia, [define by differentiation]",
        "All AML-defining recurrent genetic abnormality flags are false.",
        "No AML-defining abnormalities and blasts <20 => consider reclassification as MDS.",
        "No AML_differentiation provided.",
        "No germline predisposition indicated (review at MDT)",
        "Final classification => Not AML, consider MDS classification",
        "AML classifier indicated that the case is not AML. Switching to MDS classification...",
        "Default classification set to: MDS, unclassifiable",
        "Checking for biallelic TP53: {'2_x_TP53_mutations': True, '1_x_TP53_mutation_del_17p': True, '1_x_TP53_mutation_LOH': True, '1_x_TP53_mutation_50_percent_vaf': True, '1_x_TP53_mutation_10_percent_vaf': True}",
        "TP53 conditions: 2 mutations: True, with del17p: True, with LOH: True, with \u226550% VAF: True, with \u226510% VAF + complex karyotype: False",
        "Biallelic TP53 detected => MDS with biallelic TP53 inactivation"
      ],
      "icc_derivation": [
        "Retrieved blasts_percentage: 15",
        "Default classification set to: AML, NOS",
        "No ICC AML-defining abnormality is True.",
        "Biallelic TP53 => AML with mutated TP53",
        "Blasts 10\u201319 => replaced 'AML' with 'MDS/AML'. Final classification: MDS/AML with mutated TP53",
        "No germline predisposition indicated (review at MDT)",
        "Final => MDS/AML with mutated TP53 (ICC 2022)"
      ],
      "who_disease_type": "MDS",
      "icc_disease_type": "AML",
      "are_equivalent": true,
      "difference_analysis": {
        "who_classification": "MDS with biallelic TP53 inactivation",
        "icc_classification": "MDS/AML with mutated TP53",
        "who_category": "MDS_TP53",
        "icc_category": "MDS_TP53",
        "are_equivalent": true,
        "category_match": true,
        "difference_type": null,
        "significance": "low"
      },
      "test_focus": "edge_cases",
      "timestamp": "2025-06-06T19:25:13.655717"
    }
  ],
  "timestamp": "2025-06-06T19:25:13.662126",
  "total_tests": 139
}